Halofuginone hydrobromide

Drugs of the Future

Volumn 21, Issue 6, 1996, Pages 596-599

  Pines, Mark ^a   Voldavsky, Israel ^b   Nagler, Arnon ^b  

^a VOLCANI CENTER   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; HALOFUGINONE; PLANT EXTRACT;

ARTERY MUSCLE; COLLAGEN SYNTHESIS; DOSE RESPONSE; DRUG BLOOD LEVEL; FIBROBLAST; GENE EXPRESSION REGULATION; LUNG FIBROSIS; RESTENOSIS; SHORT SURVEY; SMOOTH MUSCLE FIBER;

EID: 0029976510     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.1996.021.06.361244     Document Type: Short Survey

References (27)

1. Kivirikko, K.I. Collagens and their abnormalities in a wide spectrum of diseases. Ann Med 1993, 25: 113-26.
2. Casas, J.A., Subauste, C.P., Alarcon, G.S. A new promising treatment in systemic sclerosis: 5-Fluorouracil. Ann Rheum Dis 1987, 46: 763-7.
3. Delany, A.M., Brinckerhoff, C.E. The synthetic retinoid (4-hydroxyphenyl)retinamide decreases collagen expression in vitro in the tight-skin mouse. Arthritis Rheum 1993, 36: 983-93.
4. Karvonen, K., Ala-Kokko, L., Pihlajaniemi, T., Helaakoski, T., Henke, S., Gunzler, V., Kivirikko, K.I., Savolainen, E.R. Specific inactivation of prolyl 4-hydroxylase and inhibition of collagen synthesis by oxaproline-containing peptides in cultured human skin fibroblasts. J Biol Chem 1990, 265: 8415-9.
5. Cunliffe, C.J., Franklin, T.J., Hales, N.J., Hill, G.B. Novel inhibitors of prolyl 4-hydroxylase. 3. Inhibition by substrate analogue N-oxaloglycine and its derivatives. J Med Chem 1992, 35: 2652-8.
6. Salo, T., Oikarinen, K.S., Oikarinen, A.I. Effect of phenytoin and nifedipine on collagen gene expression in human gingival fibroblasts. J Oral Pathol Med 1990, 19: 404-7.
7. Angel, S., Weinberg, Z.G., Polishuk, O., Heit, M., Plavnik, I., Bartov, I. A connection between a dietary coccidiostat and skin tears of female broiler chickens. Poult Sci 1985, 64: 294-6.
8. Christensen, K.D., Zimmermann, N.G., Wyatt, C.L., Goodman, T.N. Mitigating the effect of halofuginone on skin strength by feeding L-proline to broiler chickens. Poult Sci 1995, 74: 1610-21.
9. Granot, I., Hurwitz, S., Halevy, O., Pines, M. Halofuginone: An inhibitor of collagen type I synthesis. Biochim Biophys Acta 1993, 1156: 107-12.
10. Choi, E.T., Callow, A.D., Sehgal, N.L., Brown, D.M., Ryan, U.S. Halofuginone, a specific collagen type I inhibitor, reduces anastomotic intimal hyperplasia. Arch Surg 1995, 130: 257-61.
11. Halevy, O., Nagler, A., Levi-Schaffer, F., Genina, O., Pines, M. Inhibition of collagen type I synthesis by skin fibroblasts of graft versus host disease and scleroderma patients: Effect of halofuginone. Biochem Pharmacol 1996, in press.
12. Fuster, V., Badimon, L., Badimon, J.J., Chesebro, J.H. The pathogenesis of coronary artery disease and the acute coronary syndromes. New Engl J Med 1992, 326: 242-5.
13. Ross, R. Pathogenesis of atherosclerosis: A prospective for the 1990s. Nature 1993, 362: 801-9.
14. Nagler, A., Miao, H.Q., Eingorn, H., Pines, M., Genina, O., Vlodavsky, I. Inhibition of collagen synthesis, smooth muscle cell proliferation and injury induced intimal hyperplasia by halofuginone. Submitted.
15. Levi-Schaffer, F., Nagler, A., Slavin, S., Knopov, V., Pines, M. Inhibition of collagen synthesis and changes in skin morphology in murine graft-versus-host disease and tight skin mice: Effect of halofuginone. J Invest Dermatol 1996, 106: 84-8.
16. Granot, I., Bartov, I., Plavnik, I., Wax, E., Hurwitz, S., Pines, M. Increased skin tearing in broilers and reduced collagen synthesis in skin in vivo and in vitro in response to the coccidiostat halofuginone. Poult Sci 1991, 70: 1559-63.
17. Nyska, M., Nyska, A., Rivlin, E., Porat, S., Pines, M., Shoshan, S., Nagler, A. Topically applied halofuginone, an inhibitor of collagen type I transcription, reduces peritendinous fibrous adhesions following surgery. Connect Tissue Res, in press.
18. McBride, W., Lange, R.A., Hillis, L.D. Restenosis after successful coronary angioplasty. New Engl J Med 1988, 318: 1734-7.
19. Nagler, A., Firman, N., Feferman, R., Cotev, S., Pines, M., Shoshan, S. Reduction in pulmonary fibrosis in vivo by halofuginone. Amer J Respir Crit Care Med, in press.
20. Beier, R.C., Rowe, L.D., El Aziz Nasr, M.I.A., Elissalde, M.H., Stanker, L.H. Extraction and HPLC analysis of halofuginone in chicken serum. J Liq Chromatogr 1994, 17: 2961-70.
21. Analytical Methods Committee. Collaborative study of a method for the determination of residues of halofuginone in chicken tissue. Analyst 1984, 109: 171-4.
22. Kinabo, L.D., McKellar, Q.A., Murray, M. Determination of halofuginone in bovine plasma by competing-ion high performance liquid chromatography after solid phase extraction. Biomed Chromatogr 1989, 3: 136-8.
23. Yamamoto, Y., Hashiguchi, R., Araki, K., Kushima, H. Simple determination of halofuginone in chicken tissue by high performance liquid chromatography. J Food Hyg Soc Jpn 1991, 32: 444-7.
24. Analytical Methods Committee. Determination of halofuginone hydrobromide in medicated animal feeds. Analyst 1983, 108: 1252-6.
25. Stanker, L.H., Elissalde, M.H., Rowe, L.D., Beier, R.C., El Aziz Nasr, M.I.A. Detection of coccidiostats by immunoassay. Food Agric Immun 1994, 6: 45-54.
26. Rowe, L.D., Beier, R.C., Elissalde, M.H., Stanker, L.H. Production and characterization of monoclonal antibodies against the poultry coccidiostat halofuginone. J Agric Food Chem 1994, 42: 1132-7.
27. Kinabo, L.D., McKellar, Q.A. Pharmacokinetics of halofuginone in cattle. Brit Vet J 1989, 145: 546-51.